APA ציטוט

Taylor, P., Christensen, R., Moosavi, S., Selema, P., Guilatco, R., Fowler, H., . . . Haraoui, B. (2019). Real-world safety data from patients with rheumatic diseases treated with CT-P13, an infliximab biosimilar: An interim analysis from an observational study. BMJ Journals.

Chicago Style (17th ed.) Citation

Taylor, P., R. Christensen, S. Moosavi, P. Selema, R. Guilatco, H. Fowler, C. Bombardier, and B. Haraoui. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.

ציטוט MLA

Taylor, P., et al. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.